ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Carcinoma
Endometrial Cancer
Ovarian Cancer
Neoplasm Metastasis

Prostate Cancer trials near Boston, MA, USA:

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer.The drug involved ...

Active, not recruiting
Prostate Cancer
Drug: Nivolumab

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Boston, Massachusetts, United States and 4 other locations

with the radioligand treatment, 177Lu-PSMA-617, is safe in treating prostate cancer and whether the combination is effective in shr ...

Enrolling
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Drug: 177Lu-PSMA-617
Drug: Carboplatin

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 2 other locations

(ADT) in the treatment of metastatic, non-metastatic, and advanced prostate cancers. The first phase of the study is to establish a...

Active, not recruiting
Metastatic Prostate Cancer
Non-metastatic Prostate Cancer
Drug: GNRH-A Goserelin
Drug: Abemaciclib

Phase 1, Phase 2

Praful Ravi, MB BCHir, MRCP

Boston, Massachusetts, United States

used to monitor response to therapy in metastatic hormone sensitive prostate cancer and can be potentially used to optimize future ...

Active, not recruiting
Metastatic Prostate Cancer
Hormone Sensitive Prostate Cancer
Device: PET/CT
Drug: 18F-rhPSMA-7.3

Phase 4

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 1 other location

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Boston, Massachusetts, United States and 92 other locations

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD2287
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Boston, Massachusetts, United States and 14 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Boston, Massachusetts, United States and 31 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Active, not recruiting
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Boston, Massachusetts, United States and 13 other locations

Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...

Enrolling
Prostate Cancer
Drug: Saruparib (AZD5305)
Drug: Darolutamide

Phase 1

AstraZeneca
AstraZeneca

Providence, Rhode Island, United States and 18 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Boston, Massachusetts, United States of America and 42 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems